首页> 美国卫生研究院文献>The Journal of Neuroscience >Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin-1 Transport Defects
【2h】

Axonal Stress Kinase Activation and Tau Misbehavior Induced by Kinesin-1 Transport Defects

机译:Kinesin-1运输缺陷引起的轴突应激激酶激活和Tau行为不当。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Many neurodegenerative diseases exhibit axonal pathology, transport defects, and aberrant phosphorylation and aggregation of the microtubule binding protein tau. While mutant tau protein in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP17) causes aberrant microtubule binding and assembly of tau into filaments, the pathways leading to tau-mediated neurotoxicity in Alzheimer's disease and other neurodegenerative disorders in which tau protein is not genetically modified remain unknown. To test the hypothesis that axonal transport defects alone can cause pathological abnormalities in tau protein and neurodegeneration in the absence of mutant tau or amyloid β deposits, we induced transport defects by deletion of the kinesin light chain 1 (KLC1) subunit of the anterograde motor kinesin-1. We found that upon aging, early selective axonal transport defects in mice lacking the KLC1 protein (KLC1−/−) led to axonopathies with cytoskeletal disorganization and abnormal cargo accumulation. In addition, increased c-jun N-terminal stress kinase activation colocalized with aberrant tau in dystrophic axons. Surprisingly, swollen dystrophic axons exhibited abnormal tau hyperphosphorylation and accumulation. Thus, directly interfering with axonal transport is sufficient to activate stress kinase pathways initiating a biochemical cascade that drives normal tau protein into a pathological state found in a variety of neurodegenerative disorders including Alzheimer's disease.
机译:许多神经退行性疾病表现出轴突病理学,运输缺陷,微管结合蛋白tau的异常磷酸化和聚集。尽管额叶痴呆和帕金森氏病中突变的tau蛋白与17号染色​​体(FTDP17)相关联,导致tau蛋白微管结合异常并组装成细丝,但该途径导致tau介导的阿尔茨海默氏病和其他神经退行性疾病的神经毒性,其中tau蛋白未经基因修饰仍然未知。为了检验假说,仅轴突运输缺陷会在不存在突变的tau或淀粉样β沉积物的情况下单独导致tau蛋白的病理异常和神经变性,我们通过缺失顺行运动驱动蛋白的驱动蛋白轻链1(KLC1)亚基来诱导运输缺陷。 -1。我们发现,衰老后,缺乏KLC1蛋白(KLC1-/-)的小鼠中早期选择性轴突运输缺陷会导致轴突病变伴细胞骨架紊乱和异常货物堆积。另外,营养不良的轴突中增加的c-jun N-末端应激激酶激活与异常tau共定位。令人惊讶的是,营养不良的轴突肿胀显示出异常的tau过度磷酸化和积累。因此,直接干扰轴突运输就足以激活应激激酶通路,从而启动生化级联反应,从而将正常的tau蛋白驱动到包括阿尔茨海默氏病在内的各种神经退行性疾病中发现的病理状态。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号